Literature DB >> 30948243

Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system applied.

David G Coughlin1, Helen Petrovitch2, Lon R White2, Joseph Noorigian3, Kamal H Masaki4, G Webster Ross2, John E Duda5.   

Abstract

Braak et al.'s 2003 paper detailing the caudo-rostral progression of Lewy body pathology (LP) formed the foundation of current understanding of disease spread in Parkinson's disease (PD); however, its methods are difficult to recreate and consequently multiple new staging systems emerged to recapitulate Braak's staging system using standard neuropathological methods and to account for other patterns of LP. Studies using these systems have documented widely variable rates of cases that 'fail to fit' expected patterns of LP spread. This could be due to population differences, features of individual systems, or may constitute under-recognized patterns of disease. We examined 324 neuropathological cases from the Honolulu Asia Aging Study and applied four different LP staging systems to determine the proportion of cases adhering to different staging methodologies and those that 'fail to fit' expected patterns of LP. Of 141 cases with LP (24: PD, 8: Dementia with Lewy bodies (DLB), 109: Incidental Lewy body disease (ILBD)), our application of Braak et al., 2003 classified 83.7%, Müller et al., 2005 classified 87.9%, Beach et al., 2009 classified 100%, and Leverenz et al., 2008 classified 98.6%. There were significant differences in the cases classifiable by the Leverenz and Beach systems versus the Braak and Müller systems (p < 0.001 for each). In this population-based autopsy cohort with a high prevalence of ILBD, the majority of cases were consistent with the progression characterized by the Braak et al. however, the determination of cases as atypical is highly dependent on the staging system applied. Published by Elsevier Ltd.

Entities:  

Keywords:  Braak staging; Dementia with lewy bodies; Incidental lewy body disease; Lewy body; Parkinson's disease

Mesh:

Year:  2019        PMID: 30948243      PMCID: PMC6739131          DOI: 10.1016/j.parkreldis.2019.03.023

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  40 in total

1.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

2.  National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.

Authors:  Thomas J Montine; Creighton H Phelps; Thomas G Beach; Eileen H Bigio; Nigel J Cairns; Dennis W Dickson; Charles Duyckaerts; Matthew P Frosch; Eliezer Masliah; Suzanne S Mirra; Peter T Nelson; Julie A Schneider; Dietmar Rudolf Thal; John Q Trojanowski; Harry V Vinters; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2011-11-20       Impact factor: 17.088

3.  Research diagnostic criteria for Parkinson's disease.

Authors:  C D Ward; W R Gibb
Journal:  Adv Neurol       Date:  1990

4.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

5.  Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability.

Authors:  Christian M Müller; Rob A I de Vos; Claude-Alain Maurage; Dietmar R Thal; Markus Tolnay; Heiko Braak
Journal:  J Neuropathol Exp Neurol       Date:  2005-07       Impact factor: 3.685

6.  Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject.

Authors:  Laura Parkkinen; Tuula Pirttilä; Markku Tervahauta; Irina Alafuzoff
Journal:  Neuropathology       Date:  2005-12       Impact factor: 1.906

7.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study.

Authors:  L White; H Petrovitch; G W Ross; K H Masaki; R D Abbott; E L Teng; B L Rodriguez; P L Blanchette; R J Havlik; G Wergowske; D Chiu; D J Foley; C Murdaugh; J D Curb
Journal:  JAMA       Date:  1996-09-25       Impact factor: 56.272

8.  Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype.

Authors:  James B Leverenz; Mark A Fishel; Elaine R Peskind; Thomas J Montine; David Nochlin; Ellen Steinbart; Murray A Raskind; Gerard D Schellenberg; Thomas D Bird; Debby Tsuang
Journal:  Arch Neurol       Date:  2006-03

9.  Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.

Authors:  J Zaccai; C Brayne; I McKeith; F Matthews; P G Ince
Journal:  Neurology       Date:  2008-03-25       Impact factor: 9.910

10.  Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance.

Authors:  Laura Parkkinen; Tuula Pirttilä; Irina Alafuzoff
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

View more
  9 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging.

Authors:  Charles H Adler; Thomas G Beach; Nan Zhang; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Shyamal H Mehta; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Christine M Belden; Jessica Powell; Sandra A Jacobson; Edward Zamrini; David Shprecher; Kathryn J Davis; Brittany N Dugger; Joseph G Hentz
Journal:  J Neuropathol Exp Neurol       Date:  2019-10-01       Impact factor: 3.685

Review 3.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Authors:  David G Coughlin; Howard I Hurtig; David J Irwin
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

Review 4.  Parkinson's disease and translational research.

Authors:  Elisabeth Dinter; Theodora Saridaki; Leonie Diederichs; Heinz Reichmann; Björn H Falkenburger
Journal:  Transl Neurodegener       Date:  2020-12-01       Impact factor: 8.014

Review 5.  The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline.

Authors:  Per Borghammer
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 6.  An Update on Medical and Surgical Treatments of Parkinson's Disease.

Authors:  Dipali Nemade; Thyagarajan Subramanian; Vikram Shivkumar
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

7.  Prodromal and advanced non-motor features of Parkinson's disease.

Authors:  Peter Kempster
Journal:  BMJ Neurol Open       Date:  2021-06-21

Review 8.  Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management.

Authors:  K Del Tredici; W H Jost; T Warnecke; K-H Schäfer; I Claus
Journal:  NPJ Parkinsons Dis       Date:  2022-03-24

9.  Tau pathology associates with in vivo cortical thinning in Lewy body disorders.

Authors:  Nicola Spotorno; David G Coughlin; Christopher A Olm; David Wolk; Sanjeev N Vaishnavi; Leslie M Shaw; Nabila Dahodwala; James F Morley; John E Duda; Andres F Deik; Meredith A Spindler; Alice Chen-Plotkin; Edward B Lee; John Q Trojanowski; Corey T McMillan; Daniel Weintraub; Murray Grossman; David J Irwin
Journal:  Ann Clin Transl Neurol       Date:  2020-10-27       Impact factor: 5.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.